Rani Therapeutics Holdings Inc (RANI)

Finanzdaten der Rani Therapeutics Holdings Inc-Aktie (RANI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.71	1.71	1.46	-	-
	4.87%10.54	10.05	10.00	7.26	10.51
Research and Development	2.79%5.02	5.16	4.91	3.22	5.51
Interest Income/Expense	90.91%0.01	0.09	0.35	0.73	0.88
Depreciation and Amortization	5.59%0.15	0.16	0.19	0.22	0.24
Operating Income/Loss	5.86%-8.83	-8.34	-8.54	-7.26	-10.51
	5.07%-8.42	-8.02	-9.07	-7.91	-11.22
Attributable To Parent	5.09%-7.39	-7.03	-10.31	-5.41	-6.69
Attributable To Noncontrolling Interest	4.89%-1.03	-0.98	1.23	-2.50	-4.53
Basic Average Shares	3.98%187.17	180.00	-	46.44	36.54
Diluted Average Shares	3.98%187.17	180.00	-	46.44	36.54
Basic Earnings Per Share	-0.04	-0.04	-	-0.12	-0.18
Diluted Earnings Per Share	-0.04	-0.04	-	-0.12	-0.18